 23. Subjects on prednisone 40 mgday or equivalent or subjects on 10 mgday prednisone and subjects who were not on a stable dose for at least 2 weeks prior to Baseline. In addition, subjects who discontinued prednisone or equivalent within 2 weeks of Baseline. 